Clarity Capital Partners LLC trimmed its holdings in DarioHealth Corp. (NASDAQ:DRIO – Free Report) by 73.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 28,250 shares of the company’s stock after selling 76,758 shares during the quarter. Clarity Capital Partners LLC owned approximately 0.09% of DarioHealth worth $32,000 at the end of the most recent quarter.
Separately, DLK Investment Management LLC increased its stake in DarioHealth by 71.6% in the third quarter. DLK Investment Management LLC now owns 100,550 shares of the company’s stock worth $113,000 after purchasing an additional 41,943 shares during the period. 33.39% of the stock is currently owned by institutional investors.
DarioHealth Stock Down 2.9 %
Shares of DRIO opened at $0.92 on Tuesday. The firm has a fifty day moving average price of $0.94 and a 200-day moving average price of $1.17. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.26 and a quick ratio of 1.96. DarioHealth Corp. has a 12-month low of $0.71 and a 12-month high of $2.60.
DarioHealth Company Profile
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Read More
- Five stocks we like better than DarioHealth
- 5 discounted opportunities for dividend growth investors
- Medicare Advantage Costs Surge: How These 2 Insurers Are Thriving
- What is Insider Trading? What You Can Learn from Insider Trading
- Mobileye’s Recovery Steadily Gains Traction with Novel AI
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Options Traders Bet Big on These 3 Tech Stocks
Receive News & Ratings for DarioHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DarioHealth and related companies with MarketBeat.com's FREE daily email newsletter.